Investigational Drug Information for Lysergic Acid Diethylamide
✉ Email this page to a colleague
What is the development status for investigational drug Lysergic Acid Diethylamide?
Lysergic Acid Diethylamide is an investigational drug.
There have been 19 clinical trials for Lysergic Acid Diethylamide.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 2nd 2019.
The most common disease conditions in clinical trials are Headache, Cluster Headache, and Anxiety Disorders. The leading clinical trial sponsors are University Hospital, Basel, Switzerland, Eleusis Therapeutics, and Canisius-Wilhelmina Hospital.
There are four hundred and sixty-three US patents protecting this investigational drug and eight international patents.
Summary for Lysergic Acid Diethylamide
| US Patents | 463 |
| International Patents | 8,931 |
| US Patent Applications | 3,147 |
| WIPO Patent Applications | 1,927 |
| Japanese Patent Applications | 1,002 |
| Clinical Trial Progress | Phase 2 (2019-01-02) |
| Vendors | 16 |
Recent Clinical Trials for Lysergic Acid Diethylamide
| Title | Sponsor | Phase |
|---|---|---|
| Lysergic Acid Diethylamide (LSD) in Palliative Care | University Hospital, Zürich | Phase 2 |
| Lysergic Acid Diethylamide (LSD) in Palliative Care | University Hospital, Basel, Switzerland | Phase 2 |
| Minidosing Lysergic Acid Diethylamide (LSD) for Chronic Cluster Headache | Leiden University Medical Center | Phase 2 |
Clinical Trial Summary for Lysergic Acid Diethylamide
Top disease conditions for Lysergic Acid Diethylamide
Top clinical trial sponsors for Lysergic Acid Diethylamide
US Patents for Lysergic Acid Diethylamide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Lysergic acid diethylamide | ⤷ Try a Trial | Tamper-resistant pharmaceutical compositions of opioids and other drugs | COLLEGIUM PHARMACEUTICAL, INC. (Canton, MA) | ⤷ Try a Trial |
| Lysergic acid diethylamide | ⤷ Try a Trial | Personal substance detection field test kit | Lindon Group, Inc. (East Providence, RI) | ⤷ Try a Trial |
| Lysergic acid diethylamide | ⤷ Try a Trial | Wearable apparatus for detecting a target substance in a liquid | Undercover Colors, Inc. (Raleigh, NC) | ⤷ Try a Trial |
| Lysergic acid diethylamide | ⤷ Try a Trial | Pharmaceutical compositions for treating or preventing pain | LOCL PHARMA, INC. (Las Vegas, NV) | ⤷ Try a Trial |
| Lysergic acid diethylamide | ⤷ Try a Trial | Combination dopamine antagonist and opiate receptor antagonist treatment of addictive behavior | University of Maryland, Baltimore (Baltimore, MD) | ⤷ Try a Trial |
| Lysergic acid diethylamide | ⤷ Try a Trial | Methods and apparatus for detecting compounds in liquids | Undercover Colors, Inc. (Raleigh, NC) | ⤷ Try a Trial |
| Lysergic acid diethylamide | ⤷ Try a Trial | Pharmaceutical compositions | LOCAL PHARMA, INC. (Las Vegas, NV) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Lysergic Acid Diethylamide
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Lysergic acid diethylamide | Australia | AU2003247876 | 2022-07-05 | ⤷ Try a Trial |
| Lysergic acid diethylamide | Canada | CA2491572 | 2022-07-05 | ⤷ Try a Trial |
| Lysergic acid diethylamide | Canada | CA2569958 | 2022-07-05 | ⤷ Try a Trial |
| Lysergic acid diethylamide | Canada | CA2916869 | 2022-07-05 | ⤷ Try a Trial |
| Lysergic acid diethylamide | Cyprus | CY1119831 | 2022-07-05 | ⤷ Try a Trial |
| Lysergic acid diethylamide | Denmark | DK1765292 | 2022-07-05 | ⤷ Try a Trial |
| Lysergic acid diethylamide | European Patent Office | EP1594467 | 2022-07-05 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
